Trials / Completed
CompletedNCT00053378
A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects
A Placebo-Controlled, Double-Blind Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 45 (planned)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A study to determine the effect of Zemplar on the regulation of serum calcium levels and the need for administration of elemental calcium in hypocalcemic intensive care patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | paricalcitol injection (Zemplar) | |
| BEHAVIORAL | Effects on calcium regulation | |
| BEHAVIORAL | Administration of elemental Ca during hypocalcemic ICU pts. |
Timeline
- Start date
- 2002-01-01
- First posted
- 2003-01-28
- Last updated
- 2006-08-02
Locations
9 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00053378. Inclusion in this directory is not an endorsement.